Download Citation
Article Source:
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
Liu CY,
Lau KY,
Hsu CC,
Chen JL,
Lee CH,
et al.
(2017)
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
PLOS ONE 12(12): e0189007.
https://doi.org/10.1371/journal.pone.0189007